GC Biopharma pushes ahead with homegrown mRNA COVID-19 vaccine using full-cycle AI
GC Biopharma has won approval for Phase 2 trials of its AI-powered mRNA COVID-19 vaccine. The company wants to secure vaccine independence for South Korea and expand its own mRNA platform into new therapies.